Clinical Trial Update: Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension [Phase 3]

View source ↗

Summary

This document reports the completion and posting of results from a Phase 3 safety and efficacy trial of ambrisentan in subjects with pulmonary arterial hyperten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• LETAIRIS (ambrisentan)

Snippet

Sponsor: Gilead Sciences | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2010-11-19